Jiadong Xia et al. performed a pan-cancer analysis comparing the activation of the TGF-β pathway among different TMEs based on multi-omics data and found that compared with non-inflamed tumors, increased TGF-β signaling activity appeared in four non-cancer cell types within TME in inflamed tumors [75]. This evidence concerns the gene TGFB1 and cancer.